See related Synvisc inj information |
|
Manufacturer |
Genzyme |
Distributor |
Berli Jucker |
Contents |
Hylan G-F 20 |
Indications |
Temporary replacement & supplement for synovial fluid. For IA use to reduce pain associated w/ OA of the knee & hips. |
Dosage |
OA of the knee 3 inj in the knee 1 wk apart. Max: 6 inj w/in 6 mth, w/ a min of 4 wk between treatment regimens. OA of the hips 1 inj in the hip. If adequate symptomatic relief is not achieved, a 2nd inj is recommended between 1 & 3 mth after the 1st inj. |
Contraindications |
Presence of venous or lymphatic stasis in the leg. Infected or severely inflamed joints or skin disease at the inj site. |
Special Precautions |
Not for use in the presence of large IA effusion. Avoid any strenuous activity after inj. Hypersensitivity to avian protein. Pregnancy. Childn <18 yr. |
Adverse Drug Reactions |
Transient pain, swelling &/or effusion in the injected joint.
View ADR Monitoring Form |
Presentation/Packing |
Form |
Packing |
Photo |
Synvisc injection |
Synvisc 8 mg/1 mL x 2 mL x 3's |
|
|
Manufacturer: |
Genzyme |
Distributor: |
Berli Jucker
|
|
|
|